- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will present at two upcoming investor conferences.
Scheduled presentations include the following:
Wells Fargo 2014 Healthcare Conference - Boston
June 17, 2014 - At 1:45 p.m. EDT Christopher Anzalone, Ph.D., President and Chief Executive Officer, will deliver a corporate presentation, and at 2:20 p.m. EDT he will participate in the "Gene Manipulation" panel discussion
Piper Jaffray GenomeRx Symposium - New York
June 23, 2014 - At 3:30 p.m. EDT David Lewis, Ph.D., Chief Scientific Officer, will participate in the "RNA/DNA: Getting It Where You Need It" panel discussion
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics. The company is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead's pipeline includes clinical programs in chronic hepatitis B virus and partner-based programs in obesity and oncology.
For more information please visit www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to .
For more information, please click here
Arrowhead Research Corporation
Vince Anzalone, CFA
The Trout Group
Martina Schwarzkopf, Ph.D.
Copyright © Arrowhead Research CorporationIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Graphenea celebrates fifth anniversary April 27th, 2015
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015